{"slideshow_credits": null, "snippet": "Despite the end of a lawsuit involving Allergan, bylaws intended to inhibit shareholder actions are all the rage in corporate America.", "abstract": "Despite the end of a lawsuit involving Allergan, bylaws intended to inhibit shareholder actions are all the rage in corporate America.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"lastname": "SOLOMON", "rank": 1, "firstname": "Steven", "role": "reported", "organization": "", "middlename": "Davidoff"}], "original": "By STEVEN DAVIDOFF SOLOMON"}, "web_url": "http://dealbook.nytimes.com/2014/09/18/allergan-valeant-fight-holds-lessons-for-all-corporate-shareholders/", "lead_paragraph": null, "headline": {"main": "Allergan-Valeant Fight Holds Lessons for All Corporate Shareholders", "kicker": "DealBook"}, "_id": "541b3b9838f0d8296cb0f49f", "word_count": "1122", "multimedia": [{"height": 126, "url": "images/2014/09/19/business/dbpix-dealprof-allergan/dbpix-dealprof-allergan-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/09/19/business/dbpix-dealprof-allergan/dbpix-dealprof-allergan-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 600, "url": "images/2014/09/19/business/dbpix-dealprof-allergan/dbpix-dealprof-allergan-articleLarge.jpg", "legacy": {"xlarge": "images/2014/09/19/business/dbpix-dealprof-allergan/dbpix-dealprof-allergan-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "600"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/09/19/business/dbpix-dealprof-allergan/dbpix-dealprof-allergan-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/09/19/business/dbpix-dealprof-allergan/dbpix-dealprof-allergan-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-09-18T16:05:16Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Ackman, William A", "rank": "1"}, {"name": "persons", "value": "Bouchard, Andre G", "rank": "2"}, {"name": "organizations", "value": "Allergan Inc", "rank": "1"}, {"name": "organizations", "value": "Pershing Square Capital Management", "rank": "2"}, {"name": "organizations", "value": "Securities and Exchange Commission", "rank": "3"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": "4"}, {"name": "subject", "value": "Boards of Directors", "rank": "1"}, {"name": "subject", "value": "Corporations", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "3"}, {"name": "subject", "value": "Insider Trading", "rank": "4"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "5"}, {"name": "subject", "value": "Suits and Litigation (Civil)", "rank": "6"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}